Levaquin Patent Upheld In Mylan Challenge
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan's ANDA infringes on valid patent, West Virginia district court finds. Patent protection runs until at least December 2010. J&J still faces litigation on the antibiotic from four other generic companies, but no trial date has been set.